STOCK TITAN

Optimi Health inks $100M equity line with Seven Knots

Optimi Health Corp. (OPTH) entered into a common share purchase agreement with Seven Knots, LLC, establishing an equity line of credit under which Optimi may, at its discretion, sell up to US$100 million of common shares over the term of the facility.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Optimi Health Corp. (OPTH) entered into a common share purchase agreement with Seven Knots, LLC, establishing an equity line of credit under which Optimi may, at its discretion, sell up to US$100 million of common shares over the term of the facility. For each draw, Seven Knots must buy the specified shares at 97% of the lower of the lowest sale price on the purchase date and the volume-weighted average price during the purchase period, with a maximum of US$2 million per draw and a price floor set at 85% of the prior day’s close or a higher Company-selected floor.

As consideration, Optimi issued Seven Knots a non-interest-bearing US$1.5 million unsecured convertible promissory note and agreed to issue a second US$500,000 note if gross ELOC sales reach US$7 million. These notes mature in 24 months and are convertible at 95% of the 20-day volume-weighted average price, with a minimum conversion price of US$3.00 per share and a 2.99% beneficial ownership cap. Optimi may prepay the notes at 100% of principal in cash, and no shares can be sold under the ELOC until a filed Form F-1 resale registration statement is declared effective by the SEC.

Positive

  • US$100 million discretionary equity line of credit provides significant potential access to capital.
  • Equity draws are capped at US$2 million per draw, allowing staged access rather than a single large issuance.
  • Convertible notes include a US$3.00 per share floor and a 2.99% beneficial ownership cap, limiting extreme dilution from any single holder.
  • Company can prepay the US$2.0 million in Commitment Notes at 100% of principal, which can eliminate further share issuance from those notes.

Negative

  • The equity line permits issuance of up to US$100 million of common shares, creating potential for substantial equity dilution.
  • Commitment financing involves a US$1.5 million convertible note and a possible additional US$500,000 note, both convertible at a 5% discount to 20-day VWAP.
  • Shares sold under the ELOC will be priced at 97% of market reference prices, embedding a discount that may pressure trading levels.
  • A Form F-1 registration for resale of shares issued under the Purchase Agreement and notes may create an overhang once effective.
Equity line of credit capacity US$100 million of common shares Maximum aggregate amount Optimi may sell to Seven Knots under the ELOC
Per-draw limit under ELOC US$2 million per draw Maximum size of each individual purchase by Seven Knots
Share purchase discount 97% of reference price Purchase price equals 97% of the lower of lowest sale price or VWAP for each draw
ELOC floor price threshold 85% of prior-day closing price Purchase period terminates if share price falls below this level or a higher Company-set floor
Initial Commitment Note principal US$1.5 million Unsecured, non-interest-bearing convertible promissory note issued to Seven Knots
Additional Commitment Note principal US$500,000 Second note to be issued if gross ELOC proceeds reach US$7 million
Convertible note maturity 24 months Maturity from respective issuance dates of the Commitment Notes
Conversion discount and floor price 95% of 20-day VWAP, with US$3.00 floor Conversion price formula for Commitment Notes
equity line of credit financial
"establishing an equity line of credit (the “ ELOC ”) under which the Company"
An equity line of credit is a loan that allows homeowners to borrow money against the value of their property, similar to having a flexible credit card secured by their home. It matters to investors because it provides a way for property owners to access cash for various needs, which can influence real estate markets and overall economic activity. This type of credit offers ongoing borrowing capacity, making it a valuable financial tool for those with significant property equity.
volume-weighted average price financial
"equal to 97% of the lower of the lowest sale price...and the volume-weighted average price"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
convertible promissory note financial
"issued to Seven Knots an unsecured, non-interest-bearing convertible promissory note"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
beneficially own financial
"to the extent that, after giving effect...would beneficially own more than 2.99%"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
registration statement on Form F-1 regulatory
"filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission"
A registration statement on Form F-1 is a legal document companies file with regulators to offer their shares to investors in a foreign country or market. It provides essential information about the company's business, finances, and risks, helping investors make informed decisions about whether to buy its stock. This process ensures transparency and protects investors by making company details publicly available before trading begins.

FAQ

What financing agreement did Optimi Health Corp. (OPTH) enter into with Seven Knots?

Optimi entered a common share purchase agreement with Seven Knots, establishing an equity line of credit to sell up to US$100 million of common shares at its discretion over the facility term, subject to pricing, per-draw limits, and other conditions described in the agreement.

How are share prices determined under Optimi Health (OPTH) equity line with Seven Knots?

For each draw, Seven Knots must purchase shares at 97% of the lower of the lowest sale price of Optimi’s common shares on the purchase date and the volume-weighted average price during the purchase period, with each draw capped at US$2 million and subject to a price floor.

What are the key terms of the convertible promissory notes issued by Optimi Health (OPTH)?

Optimi issued a non-interest-bearing unsecured convertible note for US$1.5 million and may issue a second for US$500,000 if ELOC sales reach US$7 million. They mature in 24 months and are convertible at 95% of the 20-day VWAP, with a US$3.00 floor price.

Is there a limit on how much of Optimi Health (OPTH) Seven Knots can own?

Yes. Upon conversion of the Commitment Notes, no shares may be issued if, after issuance, Seven Knots and its affiliates would beneficially own more than 2.99% of Optimi’s outstanding common shares.

When can Optimi Health (OPTH) start selling shares under the equity line of credit?

Optimi filed a Form F-1 registration statement with the SEC to register the resale of shares issuable under the Purchase Agreement and the Commitment Notes. No shares may be sold under the ELOC until this registration statement is declared effective by the SEC.

Can Optimi Health (OPTH) avoid dilution from the convertible notes with Seven Knots?

Optimi may prepay the Commitment Notes in cash at 100% of principal, without premium or penalty. Prepayment would eliminate further share issuance under those notes, subject to the timing and any conversions already made.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August

 

Commission File Number: 001-43304

 

 

 

OPTIMI HEALTH CORP.

 

 

 

269 David Brown Way

Princeton, B.C. V0X 1W0

Canada

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F

 

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit  

Description of Exhibit

99.1   Material Change Report

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       
    OPTIMI HEALTH CORP.
       
Date: August 26, 2026   By: /s/ Dane Stevens
    Name: Dane Stevens
    Title: Chief Executive Officer, Chief Marketing Officer and Director

 

 

 

 

 

 

 

 

Exhibit 99.1

 

FORM 51-102F3

 

MATERIAL CHANGE REPORT

 

  Item 1 Name and Address of Company
     
 

Optimi Health Corp. (the “Company”)
269 David Brown Way
Po Box 728

Princeton, BC V0X 1W0

     
  Item 2 Date of Material Changes
     
    August 14, 2026.
     
  Item 3 News Releases
     
    A news release with respect to the material change was disseminated by the Company on August 14, 2026, through Newsfile Corp. and filed on SEDAR+.
     
  Item 4 Summary of Material Change
     
    On August 13, 2026, the Company entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.
     
  Item 5 Full Description of Material Changes:
     
   

On August 13, 2026, the Company entered into the Purchase Agreement with Seven Knots, establishing the ELOC under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.

 

Sales under the ELOC are at the Company's discretion, subject to the terms and conditions of the Purchase Agreement. For each draw, Seven Knots is obligated to purchase the shares specified in the Company's purchase notice at a price per share equal to 97% of the lower of the lowest sale price of the common shares on the applicable purchase date and the volume-weighted average price during the applicable purchase period, subject to a maximum of US$2 million per draw. Each purchase period terminates if the share price falls below a floor equal to 85% of the closing price on the trading day prior to the day the purchase notice is delivered, or a higher price specified by the Company.

 

As consideration for Seven Knots' commitment, the Company issued to Seven Knots an unsecured, non-interest-bearing convertible promissory note in the principal amount of US$1.5 million and agreed to issue a second convertible promissory note on the same terms in the principal amount of US$500,000 if gross proceeds from sales under the ELOC equal or exceed US$7 million (together, the “Commitment Notes”). The Commitment Notes mature 24 months from their respective dates of issuance and are convertible at Seven Knots' option at a conversion price equal to 95% of the 20-day volume-weighted average price of the common shares, subject to a floor conversion price of US$3.00 per share. No shares may be issued upon conversion of the Commitment Notes to the extent that, after giving effect to the issuance, Seven Knots and its affiliates would beneficially own more than 2.99% of the Company's outstanding common shares. The Company may prepay the Commitment Notes in cash at any time at 100% of principal, without premium or penalty, eliminating any further issuance of shares under the notes.

 

The Company filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) registering the resale by Seven Knots of common shares issuable under the Purchase Agreement and the Commitment Notes. No shares may be sold under the ELOC until the registration statement is declared effective by the SEC.

 

 

 

 

  Item 6 Reliance on Section 7.1(2) of National Instrument 51-102
     
    Not applicable.
     
  Item 7 Omitted Information
     
    Not applicable.
     
  Item 8 Executive Officer
     
 

The name and business telephone number of the officer of the Company who can answer questions regarding this material change report is as follows:

     
   

Dane Stevens, Chief Executive Officer

dane@optimihealth.ca
778-899-4367

     
  Item 9 Date of Report
     
    August 24, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Filing Exhibits & Attachments

1 document